ClinicalTrials.gg
CompletedNCT07900802Updated Nov 2, 2026

Comparing Aloe Vera Gel and Clindamycin Gel Added to Scaling and Root Planing for Periodontitis

An interventional study of Scaling and Root Planing in Periodontitis, Clindamycin Gel and Aloe Vera Gel, sponsored by Suez Canal University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Suez Canal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Apr 2023, registered Oct 2026).
Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Periodontitis is an inflammatory disease affecting the tissues that support the teeth. Scaling and root planing is a standard nonsurgical treatment, but additional local treatments may help improve clinical periodontal outcomes and reduce bacterial load. This study compared scaling and root planing alone with scaling and root planing combined with locally applied Aloe vera gel or clindamycin gel in adults with periodontitis. The study evaluated clinical periodontal parameters and anaerobic bacterial counts at baseline and at 1 and 3 months after treatment. The objective was to compare the clinical and microbiological outcomes of the three treatment approaches.

Read the detailed description

This single-blind, three-arm clinical study evaluated the clinical and microbiological outcomes of locally applied Aloe vera gel and clindamycin gel as adjuncts to nonsurgical periodontal therapy.

The study included 30 adults aged 20-45 years with periodontitis, comprising 10 participants in each treatment arm. Participants were selected from the Periodontology Clinic, Faculty of Dentistry, Suez Canal University, Egypt. All participants received full-mouth scaling and root planing using manual and ultrasonic instrumentation as appropriate, together with oral hygiene instructions.

The three treatment arms were scaling and root planing alone, scaling and root planing combined with local application of Aloe vera gel, and scaling and root planing combined with local application of 2% clindamycin gel. The gels were applied subgingivally into the periodontal pockets using a blunt syringe.

Clinical periodontal assessments included plaque index, gingival index, probing pocket depth, and clinical attachment level. Gingival crevicular fluid samples were collected for microbiological assessment of anaerobic bacterial counts using culture methods.

Clinical and microbiological assessments were performed at baseline and at 1 and 3 months after treatment. The study was approved by the Research Ethics Committee, Faculty of Dentistry, Suez Canal University (approval number 522/2022). Written informed consent was obtained from participants before study procedures.

02

Conditions studied

  • Periodontitis
  • Clindamycin Gel
  • Aloe Vera Gel
  • Scaling and Root Planing

Browse trials for

Keywords

  • Periodontitis; Aloe vera gel; Clindamycin gel; Scaling and root planing; Clinical attachment level; Probing pocket depth; Anaerobic bacteria
03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's enrollment of 30 is below the median of 44 across 846 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Suez Canal University is the lead sponsor of 164 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 20 to 45 years.
  • Both sexes.
  • Systemically healthy individuals.
  • At least 20 natural teeth.
  • Periodontal pockets measuring 4-5 mm.
  • Participants diagnosed with Stage II, Grade B periodontitis.

Exclusion criteria

Exclusion Criteria:

  • Systemic conditions that may adversely affect periodontal status, including diabetes mellitus, hypertension, and atherosclerosis.
  • Periodontal treatment within the previous 6 months.
  • Antimicrobial therapy within the previous 3 months.
  • Smoking or alcoholism.
  • Pregnancy or lactation.
  • Parafunctional habits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Scaling and Root Planing Alone

    Participants received full-mouth scaling and root planing using manual and ultrasonic instrumentation as appropriate, together with oral hygiene instructions. No adjunctive Aloe vera or clindamycin gel was applied.

    Procedure: Scaling and Root Planing

  • Active comparator
    Aloe Vera Gel Plus Scaling and Root Planing

    Locally prepared Aloe vera gel was applied subgingivally into the periodontal pockets using a blunt syringe to fill the sulcus to its deepest point following scaling and root planing. The thesis describes Aloe vera leaf extract with hydroxypropyl methylcellulose and preservatives in the formulation.

    Procedure: Scaling and Root Planing

  • Active comparator
    Clindamycin Gel Plus Scaling and Root Planing

    Locally prepared 2% clindamycin gel was applied subgingivally into the periodontal pockets using a blunt syringe following scaling and root planing. The thesis describes a carboxymethylcellulose-based gel formulation.

    Procedure: Scaling and Root Planing

Interventions

  • ProcedureScaling and Root Planing

    Participants received full-mouth scaling and root planing using manual and ultrasonic instrumentation as appropriate, together with oral hygiene instructions.

06

What researchers measure

Primary outcomes

  1. Change in Clinical Attachment Level

    Change in clinical attachment level (CAL), measured in millimeters from the cementoenamel junction to the base of the periodontal pocket. Measurements were obtained using a periodontal probe and a customized acrylic stent to improve reproducibility.

    Time frame: Baseline, 1 month and 3 months after treatment.

  2. Change in Probing Pocket Depth

    Change in probing pocket depth (PPD), measured in millimeters from the free gingival margin to the base of the periodontal pocket using a UNC-15 periodontal probe and a customized acrylic stent.

    Time frame: Baseline, 1 month and 3 months after treatment.

Secondary outcomes

  1. Anaerobic bacterial count

    Change in anaerobic bacterial colony-forming units measured by culture of gingival crevicular fluid samples

    Time frame: Baseline, 1 month, and 3 months

  2. Change in plaque index score

    Plaque Index (PI) Score, ranging from 0 to 3, with higher scores indicating a worse outcome (greater plaque accumulation).

    Time frame: Baseline, 1 month, and 3 months

  3. Change in gingival index score

    Gingival Index (GI) Score, ranging from 0 to 3, with higher scores indicating a worse outcome (greater gingival inflammation).

    Time frame: Baseline, 1 month, and 3 months

07

Study locations

1 site
  • Suez Canal University, Faculty of Dentistry
    Ismailia, Ismailia/Alsalam 41511, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2023 to primary completion in Aug 2026, 39 months.

Of 480 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's 39 months is above that.

Counting every sponsor, half of 494 studies reached it within 16 months; a quarter within 8 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Oct 28, 2026
StartActual
Apr 12, 2023
Primary completionActual
Aug 10, 2026
CompletionActual
Aug 15, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedPlaqueChange in plaque index scoreTime frame: Baseline, 1 month, and 3 months
  • EditedGingivalChange in gingival index scoreTime frame: Baseline, 1 month, and 3 months
Nov 2, 2026
Registered
First appeared on the registry
Oct 28, 2026
Show all 2 updates
  1. Nov 2, 2026
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedPlaqueChange in plaque index scoreTime frame: Baseline, 1 month, and 3 months
    • EditedGingivalChange in gingival index scoreTime frame: Baseline, 1 month, and 3 months
    + 1 other change: responsible party
  2. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07900802
Responsible party
fatma alzahraa (Principal Investigator, Suez Canal University) — Principal investigator
First posted
Oct 28, 2026
Start date
Apr 12, 2023
Primary completion
Aug 10, 2026
Completion
Aug 15, 2026
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion